CHARLES SIMONE II was named medical director of the Maryland Proton Treatment Center, effective in November. Simone will help define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System and the university’s school of medicine. He will...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
